The ketogenic diet was formally created in 1921 by Dr. Russell Wilder at the Mayo Clinic as a treatment for childhood epilepsy, but the idea behind it is far older than that. Ancient physicians noticed that fasting could stop seizures, and Wilder’s insight was that a high-fat, very-low-carbohydrate diet could mimic the metabolic state of fasting without actually starving the patient. The story of how a niche medical therapy became the most searched diet in the United States involves nearly a century of clinical ups and downs, a Hollywood father’s campaign, and a cultural shift that its inventors never anticipated.
Fasting as Medicine in the Ancient World
Long before anyone understood metabolism, healers observed that going without food sometimes reduced the frequency of seizures. Fasting and other dietary restrictions were used to treat epilepsy as far back as biblical times, and references to the practice appear across multiple ancient medical traditions.1PubMed. The use of diet in the treatment of epilepsy The reasoning was religious or mystical in many cases, but the clinical observation was real: people who fasted sometimes had fewer seizures. That observation would sit largely unexplored for centuries before modern medicine picked it up.
The first formal medical publication connecting fasting to seizure control came in 1911, when two French physicians, Guelpa and Marie, described a protocol involving four days of fasting with only water and a sodium sulfate solution, followed by a restricted vegetarian diet. They repeated the cycle roughly every eight days and reported improvement in six patients.2Epilepsy & Behavior. History of dietary treatment from Wilder’s hypothesis to the first open studies in the 1920s By modern standards, six patients barely counts as a case series, but that paper is widely considered the starting point of modern dietary treatment for epilepsy. The problem was obvious: you cannot keep a person, especially a child, in a perpetual state of fasting. What was needed was a way to reproduce the metabolic effects of fasting through food.
Russell Wilder and the Invention of the Ketogenic Diet
The solution came a decade later. In 1921, Dr. Russell Wilder at the Mayo Clinic proposed that a diet extremely high in fat and very low in carbohydrates could push the body into the same metabolic state produced by fasting, a state in which the liver converts fat into molecules called ketone bodies, which the brain and other organs can burn for fuel.3PubMed Central. Ketogenic diet: Old treatment, new beginning Wilder coined the term “ketogenic diet” and began using it with pediatric epilepsy patients. The classical version prescribed a ratio of about four grams of fat for every one gram of combined protein and carbohydrate, which is dramatically different from a normal diet and requires careful medical supervision to implement.
The approach worked. Over the following two decades, clinicians across the United States adopted the ketogenic diet for children whose seizures did not respond to the limited medications available at the time. The diet was restrictive and difficult for families to maintain, involving precise weighing of foods and near-total elimination of sugar, bread, and fruit. But for many children with severe epilepsy, it offered something no drug could: meaningful seizure reduction or, in some cases, complete seizure freedom.4PubMed. The use of diet in the treatment of epilepsy
Why the Diet Nearly Disappeared
If the ketogenic diet was working, why did it almost vanish from clinical practice? The answer is simple: drugs arrived that were easier to use. In 1938, phenytoin (sold under the brand name Dilantin) became the first anticonvulsant discovered through systematic screening, and it was effective for many patients without the grueling dietary restrictions of the ketogenic protocol. Over the next few decades, additional anticonvulsant medications followed, and physicians increasingly reached for pills instead of meal plans.5PubMed. Antiepileptic popular ketogenic diet: emerging twists in an ancient story
The decline was steep. After roughly two decades of widespread use from the 1920s through the 1940s, the ketogenic diet fell into near-obscurity within mainstream neurology.6PubMed. History of the ketogenic diet A handful of epilepsy centers, particularly Johns Hopkins, continued to offer it for patients who failed drug after drug. But for most physicians and most families, the diet was considered an outdated relic of pre-pharmaceutical medicine. That perception would hold for decades.
The MCT Variation and Keeping the Idea Alive
Even during the diet’s low period, a few researchers tried to improve on it. In 1971, Peter Huttenlocher introduced a variant based on medium-chain triglycerides (MCTs), a type of fat that produces ketones more efficiently than the long-chain fats in butter and cream. The MCT diet allowed patients to eat somewhat more carbohydrate and protein while still maintaining ketosis, making meals less monotonous and slightly easier to tolerate.7PubMed. Medium-chain triglyceride (MCT) ketogenic therapy
The MCT version did not trigger a broad revival on its own, but it kept the concept alive in clinical circles and demonstrated an important principle: you could adjust the specific composition of a ketogenic diet and still get the metabolic effect. That flexibility would later prove critical as researchers developed additional variants, including the modified Atkins diet and the low glycemic index treatment, both of which loosen the classical restrictions further while still promoting some degree of ketosis.
A Father, a Film, and a 1990s Comeback
The ketogenic diet’s return to prominence is one of the more unusual stories in modern medicine. In the early 1990s, Jim Abrahams, a Hollywood producer, brought his young son Charlie to Johns Hopkins after the boy’s severe epilepsy failed to respond to multiple medications and even brain surgery. The ketogenic diet worked where everything else had not. Abrahams went on to found The Charlie Foundation to promote awareness of the therapy and produced a 1997 television movie starring Meryl Streep, which brought the diet to the attention of millions of viewers.8PubMed Central. Epilepsy’s Big Fat Answer
The publicity drove renewed clinical and research interest. Medical centers that had abandoned the diet began offering it again, and a new generation of controlled studies confirmed what earlier clinicians had observed: the ketogenic diet substantially reduced seizure frequency in many children with drug-resistant epilepsy. The revival was not just nostalgic. It coincided with a growing recognition that roughly a third of epilepsy patients do not achieve adequate seizure control with medications alone, making dietary therapy a genuinely important clinical option rather than a curiosity.
What Ketosis Actually Does in the Brain
One of the frustrations of the diet’s history is that for most of its existence, nobody understood why it worked. Physicians could observe that seizures decreased, but the mechanism remained opaque. The basic metabolic premise is straightforward: when carbohydrate intake drops low enough, the liver begins breaking down fat into ketone bodies, primarily beta-hydroxybutyrate (BHB), acetoacetate, and acetone. The brain, which cannot directly burn fat for energy, can use these ketone bodies as an alternative fuel source.9Journal of Human Evolution. Metabolism as a tool for understanding human brain evolution: lipid energy metabolism as an example
But simply providing the brain with a different fuel does not explain why seizures stop. More recent research has begun to uncover specific neurochemical pathways. A 2024 study found that BHB increases the brain’s levels of GABA, the primary inhibitory neurotransmitter, and shifts the ratio of GABA to glutamate (the main excitatory neurotransmitter) in a direction that dampens excessive neural firing. The researchers showed that BHB accomplished this by inhibiting certain enzymes involved in gene regulation and activating a protein called SIRT4, which redirected glutamate toward GABA production.10PubMed Central. Ketogenic diet-produced β-hydroxybutyric acid accumulates brain GABA and increases GABA/glutamate ratio to inhibit epilepsy In plain terms, the ketone body BHB appears to turn down the brain’s excitatory volume and turn up its calming signals. That finding is still being validated, but it represents the most concrete mechanistic explanation to date.
From Hospital Wards to Kitchen Tables
The modern story of the ketogenic diet cannot be told without addressing its dramatic pivot from medical therapy to mainstream weight-loss strategy. This transition did not happen overnight, and it owes a great deal to Dr. Robert Atkins, whose low-carbohydrate diet books became bestsellers starting in the 1970s. The Atkins diet was not identical to a clinical ketogenic diet; it was higher in protein and less extreme in its fat-to-carbohydrate ratio, and it was designed for weight loss rather than seizure control. But the underlying metabolic logic overlapped: restrict carbohydrates enough and the body shifts toward burning fat, sometimes producing ketone bodies along the way.
The real explosion came in the 2010s. Social media, fitness influencers, and a broader cultural fascination with low-carbohydrate eating propelled “keto” from a medical abbreviation into a lifestyle brand. By 2020, the keto diet was the most Googled diet in the United States, with roughly 25 million unique searches that year. The global ketogenic diet food market was valued at nearly $10 billion in 2019, driven by products like keto-friendly snack bars, MCT oil supplements, and low-carb meal delivery services.11PubMed Central. A Review of Ketogenic Diet and Lifestyle Celebrities, podcasters, and documentaries all contributed to the cultural moment. What had begun as a carefully supervised hospital protocol for sick children had become something people tried on their own, often without medical guidance, primarily to lose weight.
That transition carries real tension. The clinical ketogenic diet is a precision tool, typically administered under the supervision of a dietitian and neurologist, with regular blood work and careful monitoring. The popular version is often a loose interpretation involving bacon and butter without the medical infrastructure. Whether the popular version delivers meaningful long-term health benefits beyond initial weight loss remains an open and actively debated question in nutrition science.
Side Effects That Come With the Territory
Any discussion of the diet’s history should acknowledge that the ketogenic diet has always come with significant side effects, even under medical supervision. The most consistent problems across nearly a century of clinical use involve the gastrointestinal tract. A systematic review of pediatric epilepsy trials found that GI issues were the most common complication both in the short term and long term, affecting roughly 44% of participants during extended use. Constipation tended to worsen over time, while vomiting and diarrhea were more common early on and sometimes improved as the body adjusted.12Seizure: European Journal of Epilepsy. Short and long-term side effects of the Classic Ketogenic Diet in pediatric epilepsy treatment: A systematic review of clinical trials
Beyond GI complaints, clinicians have historically monitored for kidney stones, elevated cholesterol, growth slowing in children, and nutritional deficiencies. These are manageable in a clinical setting with regular lab work and supplementation, but they underscore why the diet was always considered a serious medical intervention rather than a casual eating plan. The side-effect profile also helps explain why, even among epilepsy patients who benefit from the diet, adherence can be difficult over months and years.
Research Beyond Epilepsy
As understanding of the ketogenic diet’s mechanisms has deepened, researchers have started exploring whether it might help with other neurological conditions. The logic is appealing: if ketosis alters brain energy metabolism, reduces inflammation, and shifts neurotransmitter balance, those effects could theoretically benefit conditions beyond epilepsy. Review papers have summarized emerging evidence for potential roles in Alzheimer’s disease, Parkinson’s disease, and motor neuron disease, with proposed mechanisms involving mitochondrial function, oxidative stress reduction, and changes to the gut-brain axis.13PubMed Central. Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases
The enthusiasm should be tempered by the current state of the evidence. Only a small number of human studies have tested the ketogenic diet in people with Alzheimer’s or Parkinson’s, and while some have shown symptom improvement, the trials are small and the findings preliminary.14PubMed Central. Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease) Animal studies look promising, but the history of neuroscience is littered with animal findings that did not translate to humans. The research direction is legitimate and worth watching, but claiming that the ketogenic diet treats dementia would be well ahead of what the evidence supports.
Exogenous Ketones and Ketosis Without the Diet
One of the more interesting recent chapters in this story involves the development of exogenous ketone supplements, which aim to deliver the metabolic benefits of ketosis without requiring someone to follow the diet itself. The idea first emerged in the mid-1990s, and research has accelerated substantially in the past decade or so.15PubMed. Exogenous ketone esters as a potential therapeutic for treatment of sarcopenic obesity These supplements come primarily in two forms: ketone salts, which bind BHB to minerals like sodium or calcium, and ketone esters, which are metabolized in the gut to release free BHB. Both can raise blood ketone levels quickly without any change in diet, producing what researchers call “acute nutritional ketosis.”16PubMed Central. Exogenous Ketone Supplements in Athletic Contexts: Past, Present, and Future
The appeal is obvious. If ketone bodies themselves are responsible for the neuroprotective or metabolic benefits, then maybe you do not need to eat 80% of your calories from fat to get them. Athletes have explored exogenous ketones as an additional fuel source during endurance exercise, and researchers are studying them for potential therapeutic use in conditions ranging from muscle wasting to metabolic disease.17PubMed Central. Exogenous ketone supplementation: an emerging tool for physiologists with potential as a metabolic therapy The field is still young, and it remains unclear whether drinking ketone esters produces the same downstream effects as the complex metabolic shift that occurs when the entire body is running on dietary fat. Swallowing a ketone supplement is metabolically distinct from spending days in ketosis, and the two should not be assumed interchangeable.
Exogenous ketones also complicate the growing commercial landscape around keto. Many products marketed as “keto supplements” in grocery stores and online contain ketone salts at doses unlikely to produce meaningful blood ketone elevations. The gap between the research-grade ketone esters used in clinical studies and the consumer supplements on store shelves is substantial, and consumers have limited ways to tell the difference. It is a pattern familiar from other areas of nutrition: once a scientific concept becomes culturally popular, the commercial ecosystem that grows around it often outruns the evidence.
The Evolutionary Angle
One question that often surfaces in popular discussions of the ketogenic diet is whether humans are “designed” to eat this way. The evolutionary picture is more nuanced than either keto advocates or critics tend to present. Human brains are unusually large relative to body size and have correspondingly high energy demands. Unlike most organs, the brain cannot burn fat directly for energy. But it can use ketone bodies, which the liver produces from fat during periods of fasting or carbohydrate scarcity.18Journal of Human Evolution. Metabolism as a tool for understanding human brain evolution: lipid energy metabolism as an example This capacity likely provided an important survival advantage: early humans who could maintain brain function during food shortages had an edge over those who could not.
That does not mean humans evolved to be in permanent ketosis. Archaeological and anthropological evidence consistently suggests that human diets have been enormously variable across time and geography, ranging from high-carbohydrate tuber-based diets to high-fat marine mammal diets. Ketosis was almost certainly a recurring metabolic state for our ancestors, something the body slipped into during lean seasons and out of when food was abundant. Framing the ketogenic diet as “the way humans are meant to eat” overstates the case; framing it as metabolically unnatural understates it. The human body is well-equipped for ketosis, but it is also well-equipped for running on carbohydrates. The metabolic flexibility itself is arguably the key evolutionary feature, not a preference for either fuel source.